Beyond Resistance: Pulmonary Vascular Compromise as a Mechanistic Window Into Pediatric Pulmonary Hypertension
https://doi.org/10.1002/pul2.70218
Abstract
In the recent paper, Pulmonary Vascular Compromise is Associated with Survival in Pediatric Pulmonary Hypertension: a New Computational Model by Niccum et al. [1] presents an innovative computational model reframing pulmonary vascular disease through the concept of pulmonary vascular compromise (PVC), a quantifiable estimate of the proportion of pulmonary vascular surface area lost relative to an idealized normal pulmonary vascular capacity. This physiologically intuitive approach provides a fresh perspective on the pulmonary circulation, shifting focus from traditional hemodynamic descriptors toward a more structural and functional representation of pulmonary vascular health.
The authors adapt a model originally proposed by Bshouty that describes the pulmonary vascular bed as a dynamic system whose capacity can be inferred from hemodynamic measures and lung size [2]. By calculating the percent loss of theoretical vascular surface area, Niccum and colleagues translate pulmonary vascular resistance (PVR), an aggregate parameter often limited by its dependence on flow and pressure, into a more mechanistic descriptor of vascular injury and reserve. Using hemodynamic data from children with WSPH Group 1 pulmonary hypertension, they demonstrate that mean pulmonary artery pressure (mPAP) remains relatively normal until approximately 70% of pulmonary vascular cross-sectional area is lost, after which both mPAP and PVR rise steeply. Patients with > 80% PVC had significantly worse transplant-free survival, establishing this parameter as not only physiologically meaningful but also clinically prognostic. They subsequently combined this with right atrial pressure in multivariable models to derive a prognostic variable.
More from Pulmonary Circulation
A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease.